Male Experiences With Intra Cytoplasmic Sperm Injection (ICSI) and Reduced Sperm Quality
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- This is an observational study: the protocol does not assign a study treatment.
- Who it may be relevant to
- Registry conditions: Psychological Experience in Fertility Treatment, Hypogonadism, Testosteron Levels, Quality of Life. Basic parameters: from 18 years · Male.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Denmark
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Male Experiences With Intra Cytoplasmic Sperm Injection (ICSI) and Reduced Sperm Quality - Have Anything Changed the Past 15 Years?
Overview
Several international studies indicate that men with reduced semen quality often feel overlooked in the context of fertility treatment. Men who undergo fertility treatment due to their own infertility, exhibit increased concern and experience more negative emotions such as loss, stigmatization, and low self-esteem - more so than men undergoing fertility treatment for other reasons. Since 2008, there has been limited research on the experiences of male patients with infertility in Denmark. Furthermore, there is generally very little knowledge regarding the testosterone levels (hypogonadism) of male infertile patients and its association with quality of life. Thus, there is a lack of updated insight into how infertile men experience their situation today. Additionally, the present study finds it relevant to examine whether men's needs and experiences in interactions with health professionals have changed over the past 15 years.
Primary outcome measures
- Questionnaire of male experience of involvement in fertility treatment [Time frame: From the start of fertility treatment to registration of pregnancy test]
- Change in patient-experience when compared to the 2008 study conducted at The University Clinic for Fertility, Regional Hospital Skive by using the same questionaire [Time frame: From the start of fertility treatment to registration of pregnancy test]
- Correlation between male serum testosterone level and quality of life evaluated from questionnaire [Time frame: From the start of fertility treatment to registration of pregnancy test]
Secondary outcome measures (3)
- Questionnarie about the prevalence of psychological and social burden i fertility treatment [Time frame: From the start of fertility treatment to registration of pregnancy test]
- A comparison between men with reduced semen quality and men without reduced semen quality focusing on the prevalence of psychological and social burden, desire to communicate with health professionals, and serum testosterone level and life quality [Time frame: From the start of fertility treatment to registration of pregnancy test]
- Classification of the examined population into APHRODITE groups [Time frame: From the start of fertility treatment to end of study]
Eligibility criteria
Inclusion criteria
- ICSI treatment caused by reduced semen quality, language (danish)
Exclusion criteria
- PESA/TESA, Cancer, Sterilized males
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: Yes
Study design
- Observational model
- Cohort
Study locations
Denmark · 1 center
- Regionshospitalet — Skive
Identifiers
NCT: NCT07546435 · Male infertility